Blackwater fever in children, Burundi

Emerging Infectious Diseases

Volumn 11, Issue 7, 2005, Pages 1118-1120

  Gobbi, Federico ^a,d   Audagnotto, Sabrina ^a   Trentini, Laura ^a   Nkurunziza, Innocent ^b   Corachan, Manuel ^c   Di Perri, Giovanni ^a  

^a Clinica Malattie Infettive   (Italy)

^b Hopital de Kiremba   (Burundi)

^c University Hospital   (Spain)

^d AMEDEO DI SAVOIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER; CORTICOSTEROID; QUININE;

ADOLESCENT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BURUNDI; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; HEMOGLOBINURIA; HUMAN; HUMAN CELL; INTRAVASCULAR HEMOLYSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PATHOGENESIS; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 21144448970     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1107.041237     Document Type: Article

References (14)

1. Bruce-Chwatt LJ. Quinine and the mystery of blackwater fever. Acta Leiden. 1987;55:181-96.
2. White NJ. Malaria. In: Cook GC, Zumla AI, editors. Manson's tropical diseases. XXI ed. Philadelphia: W.B. Saunders; 2003. p. 1205-95.
3. Bruneel F, Gachot B, Wolff M, Regnier B, Danis M, Vachon F, et al. Resurgence of blackwater fever in long-term European expatriates in Africa: report of 21 cases and review. Clin Infect Dis. 2001;32: 1133-40.
4. Van den Ende J, Coppens G, Verstraeten T, Van Haeghenborgh T, Depraetere K, Van Gompel A, et al. Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health. 1998;3:632-9.
5. Bisoffi Z, Marocco S, Montera G, Marsiaj M. Acute intravascular haemolysis (blackwater fever) after malarial treatment. Trop Med Int Health. 1999;4:72-3.
6. Bruneel F, Gachot B, Wolff M, Bedos JP, Regnier B, Danis M, et al. Blackwater fever. Presse Med. 2002;31:1329-34.
7. Rogier C, Imbert P, Tail A, Sokhna C, Spiegel A, Trape JF. Epidemiological and clinical aspects of blackwater fever among African children suffering frequent malaria attacks. Trans R Soc Trop Med Hyg. 2003;97:193-7.
8. Price R, Van Vugt M, Phaipun L, Luxemburger C, Simpson J, McGready R, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg. 1999;60:547-55.
9. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(Suppl1):S1-74.
10. Tran TH, Day NP, Ly VC, Nguyen TH, Pham PL, Nguyen HP, et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis. 1996;23:1274-81.
11. Bonora S, De Rosa FG, Boffito M, Rossati A, Di Perri G. Rising temperature and the malaria epidemic in Burundi. Trends Parasitol. 2001;17:572-3.
12. Etchegorry MG, Matthys F, Galinski M, White NJ, Nosten F. Malaria epidemic in Burundi. Lancet. 2001;357:1046-7.
13. Ndayiragije A, Niyungeko D, Karenzo J, Niyungeko E, Barutwanayo M, Ciza A, et al. Efficacy of therapeutic combinations with artemisinin derivatives in the treatment of non complicated malaria in Burundi. Trop Med Int Health. 2004;9:673-9.
14. Warrel DA. Clinical features of malaria. In: Warrel DA, Gilles HM, editors. Essential malariology. Fourth ed. London: Arnold; 2002. p. 191-205.